Jim Simons Evogene Ltd. Transaction History

Renaissance Technologies LLC

$56.7 Billion
Q2 2024

A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Evogene Ltd. stock. As of the latest transaction made, Renaissance Technologies LLC holds 44,700 shares of EVGN stock, worth $111,750. This represents 0.0% of its overall portfolio holdings.

Number of Shares

44,700

Previous 44,800 0.22%

Holding current value

$111,750

Previous $34,000 14.71%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	SELL	$0.61 - $0.82 $61 - $82	-100 Reduced 0.22%	44,700 $29,000
Q4 2023 Feb 13, 2024	SELL	$0.47 - $0.88 $282 - $528	-600 Reduced 1.32%	44,800 $38,000
Q2 2023 Aug 11, 2023	SELL	$0.56 - $1.2 $40,764 - $87,351	-72,793 Reduced 61.59%	45,400 $49,000
Q1 2023 May 12, 2023	BUY	$0.59 - $0.86 $16,810 - $24,503	28,493 Added 31.76%	118,193 $74,000
Q4 2022 Feb 13, 2023	SELL	$0.61 - $8.13 $2,572 - $34,292	-4,218 Reduced 4.49%	89,700 $63,000
Q3 2022 Nov 14, 2022	SELL	$0.73 - $8.65 $120,220 - $1.42 Million	-164,686 Reduced 63.68%	93,918 $78,000
Q2 2022 Aug 12, 2022	SELL	$0.75 - $1.33 $150,357 - $266,634	-200,477 Reduced 43.67%	258,604 $199,000
Q1 2022 May 13, 2022	BUY	$1.09 - $1.83 $170,820 - $286,790	156,716 Added 51.83%	459,081 $597,000
Q4 2021 Feb 11, 2022	BUY	$1.63 - $2.83 $60,578 - $105,176	37,165 Added 14.01%	302,365 $496,000
Q3 2021 Nov 12, 2021	BUY	$2.45 - $3.45 $415,030 - $584,430	169,400 Added 176.83%	265,200 $700,000
Q2 2021 Aug 13, 2021	BUY	$3.3 - $5.02 $316,140 - $480,915	95,800 New	95,800 $328,000
Q4 2020 Feb 10, 2021	SELL	$2.41 - $5.63 $61,214 - $143,002	-25,400 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$0.97 - $4.08 $24,638 - $103,632	25,400 New	25,400 $101,000

Others Institutions Holding EVGN

# of Institutions

Shares Held

3.94M

Call Options Held

400

Put Options Held

View Full List

About Evogene Ltd.

Ticker EVGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,202,000
Market Cap $103M
Description
Evogene Ltd., together with its subsidiaries, operates as a computational biology company. It focuses on product discovery and development in multiple life-science based industries, including human health and agriculture, through the use of its Computational Predictive Biology (CPB) platform. The CPB platform, incorporating a deep understanding ...

More about EVGN

Track Jim Simons's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Account